📋 FDA Reference

Angiosculpt RX Ptca Scoring Balloon Catheter Angiosculpt Evo RX Ptca Scoring Balloon Catheter with Hydrophilic Coating

Spectranetics Corporation

Ask about this device Compare similar devices

Summary: The AngioSculpt RX PTCA Scoring Balloon Catheter is a device used in percutaneous transluminal coronary angioplasty (PTCA) to treat coronary artery disease. It is primarily used by interventional cardiologists to improve blood flow in narrowed coronary arteries.

FDA Clearance Information

Pathway ? PMA
Number ? P050018 ↗
Decision Date ? July 7, 2023
Product Code ? NWX
Device Class ? Class 3
Evidence ? 419 studies

The AngioSculpt RX PTCA Scoring Balloon Catheter, manufactured by Spectranetics, was cleared by the FDA under PMA P050018 on July 7, 2023. It is classified as a Class 3 medical device.

What It Is

The AngioSculpt RX PTCA Scoring Balloon Catheter is a specialized balloon catheter designed to facilitate the dilation of stenotic coronary arteries during angioplasty. It features a unique scoring element that helps modify plaque and improve luminal gain. The device's hydrophilic coating enhances deliverability through tortuous vessels, making it a valuable tool in complex coronary interventions.

FDA-Cleared Indications

  • Alternate supplier for a catheter component under PMA P050018.
  • Use is limited to the specific catheter component configuration and labeling reviewed by the FDA.

Clinical Applications

  • Use as a labeled component of a PTCA catheter system.
  • Use during coronary angioplasty when the complete catheter system is used according to its FDA-approved labeling.

Reported off-label uses

  • Scoring-balloon angioplasty for plaque modification before coronary stent placement is a recognized use of this device category, but it should not be assumed to be FDA-approved for this specific record unless stated in the current labeling.
  • Use in peripheral arteries is reported for some scoring-balloon catheter platforms, but should not be performed with this device unless specifically authorized by its labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The FDA record describes this product as an alternate supplier for a catheter component; confirm compatibility with the complete catheter system and the current manufacturer instructions for use.
  • Available diameter and working-length options depend on the specific catheter configuration. Match the selected size to the target vessel and lesion according to labeling.
  • The catheter is used over a compatible coronary guidewire under fluoroscopic imaging, generally through arterial access such as the radial or femoral artery.
  • The hydrophilic coating may improve tracking, but the catheter must be handled according to the instructions for use to avoid coating damage or loss of device performance.
  • MRI safety, contraindications, balloon-pressure limits, and other device-specific restrictions should be verified in the current labeling; do not assume MR safety from the coating or catheter design alone.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the AngioSculpt RX PTCA Scoring Balloon used for?

It is used for dilating narrowed coronary arteries during angioplasty, particularly in challenging lesions with calcification.

What specialties typically use this device?

Interventional cardiologists primarily use this device in catheterization labs during coronary angioplasty procedures.

What are the FDA-cleared indications?

The device is indicated as an alternate supplier for a catheter component in coronary angioplasty, used to treat coronary artery disease.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you